Abstract:BACKGROUND: Compared with utero transplantation in large animals such as goat, the utero heterogeneous hematopoietic stem cell transplantation in small animals such as mouse is facing difficulties. Rebuilding rate of heterogeneous hematopoietic stem cells in peripheral blood was below 1%. OBJECTIVE: To observe rebuilding rate of heterogeneous hemopoiesis following human cord blood hematopoietic stem cell transplantation in mouse yolk sac, and to compare with outcomes of abdominal transplantation. DESIGN, TIME AND SETTING: The cytology in vivo experiment was performed at the Laboratory of Stem Cells and Regenerative Biology, Beijing University in October 2007. MATERIALS: Cord blood from healthy newborns was collected at the Maternal and Child Health Hospital of Beijing Haidian District. ICR mice were obtained from Animal Experimental Center of Medical Department of Peking University, including 8 mice at gestational day 8.5, and 9 mice at gestational day 12.5. Phycoerythrin labeled anti-human CD45 monoclonal antibody and flow cytometer were purchased from BD. METHODS: Human cord blood mononuclear cells were harvested by Ficoll method. CD34+ cells were purified and collected using magnetic bead sorting. Mice at gestational day 8.5 were anesthestized prior to abdominal cavity was opened to expose uterus. Under a microscope, 5-10 μL cord blood CD34+ cells (5×104) were harvested, and slowly injected into the yolk sac of fetus. Under the same operation condition, the same volume of cord blood CD34+ cells were injected into the abdominal cavity of mice at gestational day 12.5. Needles were rapidly taken. Pregnant mouse uterus was homing, and then the abdominal cavity was sutured for continued pregnancy, waiting for parturition. At 3 months after birthing, blood was obtained via the caudal vein. In the dark, phycoerythrin labeled anti-human CD45 monoclonal fluorescent antibody was added. Flow cytometry was used to measure CD45 expression. Rebuilding effect of human blood cells in mice in vivo was detected by positive rate. MAIN OUTCOME MEASURES: Effects of different transplanted methods on hematopoiesis reconstitution. RESULTS: Totally 52 healthy mice were born by yolk sac injection of CD34+ cells. Three month later, 86.5% (45/52) mice presented CD45-positive reaction, with a high chimerism rate of 4.34%. Totally 48 healthy mice were born by abdominal cavity injection of CD34+ cells. Three month later, 81.3% (39/48) mice presented CD45-positive reaction. The chimerism rate was significantly lower compared with the yolk sac injection (t=2.363, P < 0.05). CONCLUSION: Yolk sac transplantation in an early stage can obtain a long-term reconstruction of hematopoietic stem cells in mice, and the outcome is better than the abdominal cavity transplantation. It also confirmed the possibility of establishing humanized blood mouse models with human cord blood hematopoietic stem cells using yolk sac transplantation.

A Chimeric Mouse Model Established by Allogenic in Utero Transplantation.

Hematopoietic Stem Cell Engraftment by Early-Stage in Utero Transplantation in a Mouse Model.

Fetal Microchimerism in the Maternal Mouse Brain: A Novel Population of Fetal Progenitor or Stem Cells Able to Cross the Blood-Brain Barrier?

The Human-mouse Chimera Nude Mouse Model Set Up from Umbilical Cord Blood Transplantation

Chimeric Mice after Blastocysts Injection of Embryonic Stem Cells from 1 Day Mice

Construction of humanized blood mouse models using human cord blood CD34~+ cells by yolk sac transplantation

Effects of chimerism on the mice heart transplanted survival with the bone marrow infusion.

Role of Fetal Stem Cells in Maternal Tissue Regeneration

Double Chimerism in Recipient by Transplantation of Two Allogeneic MHC-Mismatched Mouse Fetal Blood Units

Establishment of a Murine Model of Allogeneic Umbilical Cord Blood Transplantation

Generation of rat blood vasculature and hematopoietic cells in rat-mouse chimeras by blastocyst complementation

[A pilot study on establishment of human/pig hematopoietic chimera model in fetal and neonatal pigs]

Mouse chimeras as a system to investigate development, cell and tissue function, disease mechanisms and organ regeneration

The Potential of Rat Inner Cell Mass and Fetal Neural Stem Cells to Generate Chimeras

Primate Primordial Germ Cells Acquire Transplantation Potential by Carnegie Stage 23

Mouse Heterotopic Abdominal Heart Transplant Model

Production of viable adult trisomy 17 reversible diploid mouse chimeras

Chimerism as the basis for organ repair

Germ Cell Transplantation in Infertility Mouse

Study on the Production of Chimeras Derived from the Transgenic Embryonic Stem Cells by Blastocysts Injection

The Effect on Chimeric Embryo Construction from Fibroblasts and Early Embryos about Mouse Embryoid Body